Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Interleukin inhibitors for psoriatic arthritis

Información

DOI:
https://doi.org/10.1002/14651858.CD013043Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 13 junio 2018see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Salud musculoesquelética

Copyright:
  1. Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Gaurav Sharma

    Correspondencia a: Internal Medicine, Seth GS Medical College and KEM Hospital, Mumbai, India

    [email protected]

    [email protected]

  • Amy S Mudano

    Department of Medicine ‐ Rheumatology, University of Alabama at Birmingham, Birmingham, USA

  • Jasvinder A Singh

    Department of Medicine, Birmingham VA Medical Center, Birmingham, USA

Contributions of authors

  • Title registration: GS, JAS

  • Draft the protocol: GS, JAS

  • Review and edit the protocol: GS, ASM, JAS

Sources of support

Internal sources

  • Birmingham VA Medical Center, USA.

    JAS is supported by resources and facilities at the Birmingham VA Medical Center, Birmingham, Alabama USA.

  • University of Alabama at Birmingham, USA.

    This work is supported by the Network Meta‐analysis Cochrane Satellite of the Musculoskeletal Center that is supported by the Division of Rheumatology at the University of Alabama at Birmingham.

External sources

  • No sources of support supplied

Declarations of interest

Gaurav Sharma and Amy S Mudano have no conflicts.

Jasvinder A Singh has received research grants from Takeda and Savient and consultant fees from Savient, Takeda, Regeneron and Allergan. JAS is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms‐length funding from 36 companies; a member of the American College of Rheumatology's Guidelines Subcommittee of the Quality of Care Committee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee

Acknowledgements

None

Version history

Published

Title

Stage

Authors

Version

2018 Jun 13

Interleukin inhibitors for psoriatic arthritis

Protocol

Gaurav Sharma, Amy S Mudano, Jasvinder A Singh

https://doi.org/10.1002/14651858.CD013043

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.